- Home
- DUKRW vs TCRT Comparison
DUKRW vs TCRT Comparison
Compare DUKRW & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.22
HOLD
Current Price
$1.76
Company Overview
Basic Information| Metric | DUKRW | TCRT |
|---|---|---|
| Founded | N/A | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.9M |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DUKRW | TCRT |
|---|---|---|
| Price | $1.22 | $1.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.4K | ★ 8.9K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.66 |
| EPS | ★ N/A | N/A |
| Revenue | $377,000.00 | ★ $15,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 249.07 | N/A |
| 52 Week Low | $0.10 | $1.75 |
| 52 Week High | $1.78 | $4.57 |
Technical Indicators
Market Signals| Indicator | DUKRW | TCRT |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 29.15 |
| Support Level | $0.82 | N/A |
| Resistance Level | $1.29 | $2.02 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 65.48 | 9.37 |
Price Performance
Historical Comparison DUKRW
TCRT
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.